Target
Mu-type opioid receptor
Ligand
BDBM50287928
Substrate
n/a
Meas. Tech.
ChEBML_138744
Ki
0.100000±n/a nM
Citation
 Derrick, IMoynihan, HABroadbear, JWoods, JHLewis, JW 6N-Cinnamoyl-β-naltrexamine and its p-nitro derivative. High efficacy κ-opioid agonists with weak antagonist actions Bioorg Med Chem Lett 6:167-172 (1996)    Article 
Target
Name:
Mu-type opioid receptor
Synonyms:
M-OR-1 | MOR-1 | Mu opioid receptor | Mu-type opioid receptor (Mu) | OPIATE Mu | OPRM1 | OPRM_CAVPO
Type:
Enzyme Catalytic Domain
Mol. Mass.:
11165.58
Organism:
GUINEA PIG
Description:
P97266
Residue:
98
Sequence:
YTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKTVNVCNWI
  
Inhibitor
Name:
BDBM50287928
Synonyms:
1N-[4-cyclopropylmethyl-10,17-dihydroxy-(5R,13R,14R,17S)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10-trien-14-yl]-3-(4-chlorophenyl)-(E)-2-propenamide | CHEMBL296693
Type:
Small organic molecule
Emp. Form.:
C29H31ClN2O4
Mol. Mass.:
507.02
SMILES:
Oc1ccc2C[C@H]3N(CC4CC4)CCC45[C@@H](Oc1c24)[C@@H](CC[C@@]35O)NC(=O)\C=C\c1ccc(Cl)cc1 |THB:8:7:22:18.4.5|
Structure:
Search PDB for entries with ligand similarity: